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Summary.-Benz(a)anthracene injected subcutaneously during the first 3 days of
life caused a dose related increase in the incidence of liver and lung tumours in
Swiss mice but over a similar dose range, the K region epoxide of benz(a)anthracene
was less effective. Neonatally injected 7-methylbenz(a)anthracene was consider-
ably more active thanits Kregion epoxide inincreasing the incidence ofliver tumours
in males. Both the parent compound and the epoxide slightly raised the incidence
of lung tumours. Both chrysene and its K region epoxide increased liver tumour
incidence but not lung tumour incidence. The K region epoxides of dibenz(a,h)-
anthracene and 3-methylcholanthrene were without apparent effect on the incidence
of liver, lung or other tumours despite indications from previously reported studies
that the parent hydrocarbons are active at the same dose levels. The K region
epoxide of phenanthrene had no effect on the incidence of any kind of neoplasm.
THE HYPOTHESIS that the carcino-
genicity of polycyclic hydrocarbons is
associated with the formation of epoxide
metabolites (Grover, Hewer and Sims,
1971, 1972; Keysell et al., 1973) is sup-
ported by some experimental evidence
but remains unproven. The original com-
parative carcinogenicity data from 3
laboratories showed that K region ep-
oxides were less potent than the parent
hydrocarbons either when applied topic-
ally or when administered subcutaneously
(Boyland and Sims, 1967; Sims, 1967;
Miller and Miller, 1967; Van Duuren et
al., 1967). More recent studies with
epoxides in 2 in vitro transformation
systems (Berwald and Sachs, 1963; Chen
and Heidelberger, 1969) have demon-
strated that several K region derivatives
are more active than the corresponding
hydrocarbons ininducing malignant trans-
formation (Grover et al., 1971; Mar-
quardt et al., 1972; Huberman et al.,
1972), but others are not (Marquardt et
al., 1974). The epoxides can also act
as alkylating agents (Grover and Sims,
1970) and as mutagens (Ames, Sims and
Grover, 1972; Huberman et al., 1971;
Cookson, Sims and Grover, 1971; Fahmy
and Fahmy, 1973). Rapidly dividing
cell populations, like those used in the in
vitro transformation systems, might be
expected to be more susceptible to reactive
carcinogens, like epoxides, than mitotic-
ally inactive tissues if reactions with
cellular constituents at a particular stage
of the cell cycle are important (Bertram
andHeidelberger, 1974; Marquardt, 1974).
The newborn mouse, which is susceptible
to carcinogenic polycyclic hydrocarbons
(Roe, Rowson and Salaman, 1961; Roe,
Mitchley and Walters, 1963; Walters and
Roe, 1964, 1966) can be considered as a
convenient source of several types of
rapidly dividing cells. Consequently we
have tested the K region epoxides derived
from phenanthrene, benz(a)anthracene,
7-methylbenz(a)anthracene, dibenz(a,h)-
anthracene, chrysene and 3-methylchol-
anthrene, together with some of theCARCINOGENICITY OF POLYCYCLIC HYDROCARBON EPOXIDES IN MICE 183
parent hydrocarbons, for carcinogenicity
using newborn mice. This paper presents
the results that were obtained in these
experiments.
MATERIALS AND METHODS
The polycyclic hydrocarbon epoxides,
phenanthrene 9,10-oxide, benz(a)anthracene
5,6-oxide, 7-methylbenz(a)anthracene 5,6-
oxide, dibenz(a,h)anthracene 5,6-oxide, chry-
sene 5,6-oxide and 3-methylcholanthrene
11,12-oxide were prepared from the parent
hydrocarbons (Newman and Blum, 1964;
Boyland and Sims, 1965; Sims 1966).
Two experiments were undertaken fol-
lowing similar protocols. For each experi-
ment Swiss mice from a specific pathogen-
free colony were time mated so as to produce
a large number of litters over the course
of 2 or 3 days. Newvborn mice from each
litter were randomly allocated to various
treatment and control groups and 6 or 7
similarly treated baby mice derived from
different litters returned to each mother
mouse that had contributed her own litter
to the pool.
Test compounds were suspended in poly-
ethylene glycol (PEG) 400 and injections of
0-02 ml of the suspension were given by
introducing a 25 gauge hypodermic needle
through the skin near the root of the tail
and threading it subcutaneously to deliver
the injected material in the interscapular
region. Injections were given to every
mouse on the first day or first 3 days of life.
The details of treatments and numbers of
mice of each sex in each group are shown in
Table I (Experiment I) and Table II (Ex-
periment II).
Surviving mice were weaned when they
were 21 days old. Thereafter, males and
females were separated and housed 6 per
cage in metal boxes. A mixture of sawdust
and wood shavings was used as bedding.
The mice were fed on a standard cubed diet
(Formulation 86 from C. Holdman and Sons
(Plowco Feeds), Byers Lane, South Godstone,
Surrey) and water was given ad libitum.
Mice were inspected daily, and at weekly
intervals they were weighed and palpated
for tumours and other lesions. Mice that
were sick or had palpable tumours were
killed and examined by a standard post-
miiortem procedure. The experiment was
terminated when surviving mice were between
70 and 75 weeks old. A full routine post-
mortem examination, which included disten-
sion of the urinary bladder with fixative,
was carried out. The number of lesions
thought to be neoplasms and the size of the
largest such lesion in each organ affected
were recorded.
All tissues with suspected neoplasms were
fixed in Bouin's solution. Haematoxylin
and eosin stained 5 ,um paraffin wax sections
were prepared and examined microscopically.
RESULTS
The results of the two experiments
in terms of tumour incidence are sum-
marized in Tables II and IV.
Comparison of benz(a)anthracene and its
K region epoxide
Benz(a)anthracene (Groups A, B and
C) had a dose related effect on the inci-
dence of liver tumours in male mice and
of lung tumours in mice of both sexes.
The effect on incidence was manifest in
terms both of the proportion of animals
killed between the 70th and 75th weeks
of the experiment that had at least one
tumour of either type and in terms of
the proportion of such animals with
multiple tumours of these types. In all
3 groups treated with benz(a)anthracene
the incidence of both lung and liver
tumours was higher than in mice exposed
to the vehicle, PEG 400, only (Group G).
By comparison, the epoxide of benz(a)-
anthracene was less active than the
parent compound. At the lowest level
of dosage (Group F-3 x 50 ,tg) the
incidence of the 2 kinds of tumour was
not very different from that in Group G.
At the 2 higher levels (Groups D and E)
treatment was associated with an increase
in incidence of liver tumours in males,
but the effect was more marked in Group
E than in Group D and it was only in
Group E females that an increased inci-
dence of lung tumours was apparent.
Histologically, the liver tumours were
all of parenchymal cell origin, ranging
in appearance from well differentiatedP. L. GROVER, P. SIMS, B. C. V. MITCHLEY AND F. J. C. ROE
TABLE I.-Experiment I: Comparison ofEffects ofBenz(a)anthracene and ofits K Region
Epoxide
Treatment on Days 0, 1 and 2
(all treatments given in 0 02 ml PEG 400)
Compound Dose per treatment
Benz(a)anthracene 200 ,ug
Benz(a)anthracene 100,g
Benz(a)anthracene 50 ,ug
Benz(a)anthracene 5,6-oxide 200 ,ug
Benz(a)anthracene 5,6-oxide 100 ,ug
Benz(a)anthracene 5,6-oxide 50 jug
PEG 400 only
No. of mice
injected
(6' + O)
87
70
83
75
78
84
83
No. of mice weaned
(Day 21)
Total & y
38 19 19
46 28 18
58 32 26
46 22 24
52 27 25
37 18 19
50 26 24
TABLE II.-Experiment I: Incidence ofLung, Liver and Other Neoplasms
No. of survivors
at
50 70
weeks weeks
d 18 15
y 18 18
6S 25 19
y 17 13
6S 29 25
Sy 25 21
d 21 18
y 21 20
&27 26
S 24 22
J 16 16
y 18 16
, 22 22
$ 23 23
No. of mice examined at
p.m. from 50th-70th week
with
Liver Lung Other
tumours tumours tumours
1
0
4
0
3
0
2
0
0
0
0
0
0
0
1
0
1
2
1
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
No. of mice examined at p.m. at termination
of experiment (70th-75th week) with
I I
Multiple
Liver liver
tumours tumours
15 15
2 1
15 11
0 0
9 5
2 1
5 4
2 0
12 8
0 0
4 1
0 0
4 0
1 0
Lung
tumours
4
10
5
5
5
7
2
1
3
6
5
2
3
1
Multiple
lung
tumours
4
10
3
2
2
3
1
0
0
5
1
0
1
2
Other
tumours
0
1
1
0
0
0
2
0
0
1
0
2
0
0
TABLE III.-Experiment II: Comparison of Effects of Chrysene and 7-Methylbenz(a)-
anthracene and their Respective K Region Epoxides and Assessment of the Carcino-
genic 4ctivity of the K Region Epoxides ofPhenanthrene, Dibenz(a,h)anthracene and
3-Methylcholanthrene
Treatment on Day 0 only or on Days 0, 1 and 2
(all treatments given in 0 02 ml PEG 400)
t A .A
Compound
Chrysene
Chrysene 5,6-oxide
7-Methylbenz(a)anthracene
7-Methylbenz(a)anthracene 5,6-oxide
Phonanthrene 9,10-oxide
Dibenz(a,h)anthracene 5,6-oxide
3-Methylcholanthrene 11,12-oxide
PEG 400 only
PEG 400 only
Dose per
treatment No. of
(pg) treatments
100 3
100 3
100 3
100 3
100 3
60 1
60 1
3
- 1
No. of mice
No. of mice weaned (Day 21)
injected , A
(&+ ?) Total ,3
104 51 29 22
107 47 24 23
91 49 26 23
122 45 20 25
111 32 19 13
93 43 21 22
86 60 31 29
96 52 34 18
94 48 25 23
Group
A
B
C
D
E
F
G
Group
A
B
C
D
E
F
G
Group
H
I
J
K
I,
M
N
0
p
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TABLE IV.-Experiment II: Incidence ofLung, Liver and Other Neoplasms
No. of survivors
at
50 70
weeks weeks
6 28 27
? 22 21
6 23 21
? 22 20
6 23 4
? 21 10
c 20 20
? 25 22
6 19 17
? 13 13
6 19 16
? 20 19
6 28 26
y 27 25
63 33 30
y 15 15
6 24 20
? 23 21
No. of mice examined at
p.m. from 50-70th week
with
A
Liver Lung Other
tumours tumours tumours
0 0 0
0 0 0
0 0 0
0 0 0
11 10 0
0 7 1
0 0 0
0 1 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
No. of mice examined at p.m. at ternination
of experiment (70-75th week) with
A
Liver
tumours
13
0
8
1
1
0
4
0
4
2
2
0
6
0
9
0
3
3
Multiple
liver
tumours
6
0
3
0
1
0
2
0
1
1
1
0
1
0
1
0
2
0
Lung
tumours
1
0
0
3
1
2
6
2
0
0
1
5
3
3
1
1
2
Multiple
lung
tumours
1
0
0
0
3
1
2
3
1
0
0
0
0
1
1
0
1
1
Other
tumours
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
0
0
0
liver cell masses that were difficult to
distinguish from normal liver tissues to
pleomorphic, invasive and metastasizing
tumours. All the tumours shown in
Table II were clearly visible at autopsy
and many were over 1 cm in diameter.
The lung tumours were all ofadenomatous
structure, arising in bronchiolar or alve-
olar epithelium. Most were benign or
locally invasive but some had metas-
stasized within the lobe or origin, or to
other lobes of the lung. The lesions
shown in Table II ranged in size from
1 mm to 8 mm diameter. Where treat-
ment was associated with an excess of
either liver tumours or lung tumours,
more tumours of all grades of malignancy
were seen. Treatment did not appear
to increase the average malignancy of the
tumours. A low incidence of other neo-
plasms was encountered. Most were cases
of lymphoma or lymphosarcoma. Their
occurrence was not related to treatment.
It is concluded that the epoxide of
benz(a)anthracene is less active than its
parent compound in increasing liver and
lung tumour incidence after parenteral
administration during early neonatal life.
Comparison
epoxide
of chrysene and its K region
In Experiment II, the incidence of
liver tumours in control male mice given
3 doses of PEG 400 at birth (Group 0)
was 9 of 30 animals killed between 70
and 75 weeks. Of these, one had 2 liver
tumours. This incidence is higher than
in similarly treated mice (Group G) in
Experiment I (4 of 22 male mice killed
between 70 and 75 weeks, none with
multiple liver tumours). Against this
background incidence, however, chrysene
(Group H) increased liver tumour in-
cidence. Neither chrysene noritsKregion
epoxide affected the incidence of lung
tumours and, if anything, the parent
compound seemed to be more active than
its epoxide.
Comparison of 7-methylbenz(a)anthracene
and its K region epoxide
In this case a striking difference was
seen between the effects of the 2 com-
pounds on liver tumour incidence in
males. Most of the animals treated with
the parent compound died, or had to
Group
H
I
J
K
L
M
N
0
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be killed because they were sick, between
the 50th and 70th week of the experi-
ment. Nevertheless, a much higher in-
cidence of liver tumours was encountered
in these animals than in animals treated
with the epoxide that were examined
post mortem between the 70th and 75th
week. The females of both groups ex-
hibited a raised incidence of lung tumours
and in this case the activity of the
epoxide was not less than that of the
parent compound.
K region epoxides of phenanthrene, dibenz-
(a,h)anthracene and 3-methylcholanthrene
In the doses tested, all 3 epoxides were
without obvious effect on the incidence
of liver, lung or other tumours. It is
highly probable that the epoxides of
dibenz(a,h)anthracene and 3-methylchol-
anthrene are less active than the parent
compounds and that the epoxide of
phenanthrene is as active as phenanthrene
itself. Groups of mice treated with the
3 parent compounds were not included,
however, in the present experiment.
DISCUSSION
The carcinogenic activity of some
K region epoxides derived from polycyclic
hydrocarbons has been tested in newborn
mice partly because of the conflicting
results that have previously been ob-
tained from tests in adult animals and
from in vitro malignant transformation
systems. There are obvious difficulties
associated with testing reactive inter-
mediates like the hydrocarbon epoxides
for carcinogenicity and it was thought
that rapidly dividing neonatal tissues
might offer some advantages over those
of adult animals, especially if factors
such as reactions with DNA at a critical
stage of the cell cycle, DNA replication
and DNA repair are involved in carcino-
genesis. Additionally, neonatal tissues
probably possess lower levels of the
microsomal epoxide hydrase that catalyses
the conversion of epoxides to dihydrodiols
(Oesch, 1973).
The results obtained in the present
experiments have confirmed the activity
of the hydrocarbons benz(a)anthracene,
7-methylbenz(a)anthracene and chrysene
in newborn mice, but show that the
K region epoxides related to these 3
hydrocarbons were not more active as
carcinogens than the parent hydrocarbons
in this test system. Although direct
comparisons were not carried out here,
the results also indicate that the K region
epoxides derived from dibenz(a,h)anthra-
cene and 3-methyleholanthrene are likely
to be less active than the corresponding
hydrocarbons, which have previously been
tested in newborn mice (Kelly and
O'Gara, 1961). The phenanthrene ep-
oxide did not appear to enhance tumour
incidence, which is not really surprising
since the parent hydrocarbon is also
inactive in newborn mice (Roe and
Walters, 1967).
In the metabolism of the polycyclic
hydrocarbons, a variety of epoxides seem
certain to be formed as the initial pro-
ducts of the oxidation of the aromatic
double bonds, a process catalysed by the
microsomal mono-oxygenases, and it is
these epoxides that are now thought to
be converted into the hydroxylated de-
rivatives that are the main metabolites
ofthe hydrocarbons. So far, most studies
of hydrocarbon epoxides have been con-
centrated, for practical reasons, on K
region epoxides, several of which have
been detected as metabolites and prepared
by synthesis, and this work has recently
been reviewed (Sims and Grover, 1974).
Although some K region epoxides were
more active than the parent hydro-
carbons in the induction of malignant
transformation of cells in culture, most
K region epoxides were found to be less
carcinogenic in adult animals and, as
reported here, are less active in newborn
mice. In addition, in cells treated with
7-methylbenz(a)anthracene, the DNA pro-
ducts formed are different from those
obtained with the corresponding K region
epoxide (Baird et al., 1973). On balance
therefore, these findings can be inter.
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preted as meaning that K region epoxides
are not the epoxide metabolites involved
in hydrocarbon carcinogenesis. This is
in accord with some very recent evidence
which suggests that the DNA products
that are formed in mammalian cells
treated with polycyclic hydrocarbons arise
from non-K region epoxides, which are
themselves derived from dihydrodiols
(Sims et al., 1974; Swaisland et al., 1974);
this new type of diol-epoxide has not yet
been examined for biological activity.
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